Skip to main content
ABBOTT LABORATORIES logo

ABBOTT LABORATORIES — Investor Relations & Filings

Ticker · ABT ISIN · US0028241000 LEI · HQD377W2YR662HK5JX27 US Manufacturing
Filings indexed 4,256 across all filing types
Latest filing 2016-03-02 Director's Dealing
Country US United States of America
Listing US ABT

About ABBOTT LABORATORIES

https://www.abbott.com

Abbott Laboratories is a global healthcare company that discovers, develops, manufactures, and sells a broad portfolio of life-changing technologies. The company's operations are focused on four core businesses: Medical Devices, Diagnostics, Nutrition, and Established Pharmaceuticals. The Medical Devices division offers solutions for cardiovascular health, diabetes care (including the FreeStyle Libre continuous glucose monitoring system), and neuromodulation. The Diagnostics segment provides a wide range of in vitro diagnostic systems and tests for hospitals, laboratories, and clinics. The Nutrition business develops and markets science-based nutritional products for people of all ages, with leading brands such as Similac, PediaSure, Ensure, and Glucerna. The Established Pharmaceuticals division provides a portfolio of branded generic medicines to consumers in emerging markets.

Recent filings

Filing Released Lang Actions
Statement of changes in Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is titled 'SEC FORM 4' and is a 'Statement of Changes in Beneficial Ownership' filed pursuant to Section 16(a) of the Securities Exchange Act of 1934. It details transactions in securities by an officer of Abbott Laboratories, including dates, amounts, and ownership forms. Form 4 filings are specifically used to report insider transactions by directors and officers. The content matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives. The document length is about 5,428 characters, which is consistent with a detailed Form 4 filing rather than a brief announcement or certification. Therefore, the correct classification is Director's Dealing (DIRS).
2016-03-02 English
Statement of changes in Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a SEC Form 4 filing, which is a statement of changes in beneficial ownership of company securities by insiders such as officers or directors. It details transactions in the company's shares by a senior officer (Senior Vice President and CFO). This type of filing reports insider trades and is not a financial report, earnings release, or management discussion. Therefore, it fits the category of Director's Dealing (DIRS). The document length and content confirm it is the actual Form 4 filing, not an announcement or certification. Confidence is high due to the clear identification of the form and its purpose.
2016-03-02 English
Statement of changes in Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a SEC Form 4 filing, which is a statement of changes in beneficial ownership of company securities by insiders such as officers or directors. It details transactions in the company's shares by a senior vice president, including dates, amounts, and ownership forms. This type of filing is specifically used to report insider trades and changes in ownership by company executives or directors. It is not an annual report, earnings release, or any other financial or governance report. Therefore, it fits the category of Director's Dealing (DIRS). The document length and content confirm it is the actual Form 4 filing, not just an announcement or certification.
2016-03-02 English
FORM 4 -
Director's Dealing
2016-02-24 English
FORM 4 -
Director's Dealing
2016-02-24 English
FORM 4 -
Director's Dealing
2016-02-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.